*By Christian Smith*
Shares of Anaplan soared after the cloud software company began trading on the New York Stock Exchange on Friday, despite making its debut at the tail end of one of the worst weeks for tech stocks in months.
Frank Calderoni, the CEO of Anaplan ($PLAN), attributed the stock's success to his company's sterling reputation among big businesses.
"It really shows that Anaplan, our platform, is really established in the business community to help them better make decisions in doing what they do," Calderoni said Friday in an interview on Cheddar.
Shares of Anaplan hit a high of over $24 per share after pricing shares at $17 apiece.
The company provides cloud-based enterprise software for financial and operations planning. It primarily targets mid- to large-sized clients, including HP ($HPQ) and Coca-Cola ($KO).
Through the IPO, Anaplan raised over $250 million in capital, which Calderoni said will be used to build new technology and invest in more foreign markets ー which already account for 40 percent of Anaplan's revenue.
"We're continuing to invest in our technology, so that we can keep it fresh and innovative over the next number of years," Calderoni said.
For full interview [click here](https://cheddar.com/videos/anaplan-soars-on-first-day-of-trading).
Some House Democrats will have to vote for McCarthy's bill if enough conservative Republicans keep their word to oppose any compromise.
Blue Bird, a maker of school buses, opened up a production facility to meet the rising demand for electric school buses.
The National Eating Disorders Association said it's replacing its staff with an artificial intelligence chatbot.
Hyundai and LG announced a partnership to build a $4.3 billion electric battery plant in Georgia.
JPMorgan announced job cuts at First Republic Bank, a month after acquiring the company.
AstraZeneca said its cancer-treatment drugs when used following chemotherapy treatment showed positive late-stage trial results for endometrial cancer patients.
The federal government is giving away for free some historic lighthouses and is also auctioning some of them off too.
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Elon Musk's brain-implant company Neuralink said it received approval from the Food and Drug Administration to begin human clinical trials.
Aileen Del Cid, head of marketing at Samsung TV Plus, sat down with Cheddar News reporter Michelle Castillo to discuss the platform's plans to stand out from the streaming competition with a new channel featuring Conan O'Brien.
